Current and emerging treatment options for nasopharyngeal carcinoma.

Current and emerging treatment options for nasopharyngeal carcinoma.

Item
http://www.wikidata.org/entity/Q36359374
Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaGeneration and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display.A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.Downregulation of Ras association domain family member 6 (RASSF6) underlies the treatment resistance of highly metastatic nasopharyngeal carcinoma cells.LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2.A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma.[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cellsThe end-of-treatment telephone response and prognosis of post-radiotherapy nasopharyngeal carcinoma patients in southern ChinaCirculating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma.The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.Glutamate Decarboxylase 1 Overexpression as a Poor Prognostic Factor in Patients with Nasopharyngeal Carcinoma.A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma.Contrast-enhanced dynamic and diffusion-weighted magnetic resonance imaging at 3.0 T to assess early-stage nasopharyngeal carcinoma.Identification of long non-coding RNA CCAT1 as an oncogene in nasopharyngeal carcinoma.Magnetic Resonance Imaging Volumetry of Primary Nasopharyngeal Cancer in Patients Treated with Induction Gemcitabine and Cisplatin Followed by Concurrent Cisplatin and Volumetric Modulated Arc Therapy
P2860

Current and emerging treatment options for nasopharyngeal carcinoma.

Item
http://www.wikidata.org/entity/Q36359374
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Current and emerging treatment options for nasopharyngeal carcinoma.
@ast
Current and emerging treatment options for nasopharyngeal carcinoma.
@en
type
label
Current and emerging treatment options for nasopharyngeal carcinoma.
@ast
Current and emerging treatment options for nasopharyngeal carcinoma.
@en
prefLabel
Current and emerging treatment options for nasopharyngeal carcinoma.
@ast
Current and emerging treatment options for nasopharyngeal carcinoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P698
P932
P356
P1433
P1476
Current and emerging treatment options for nasopharyngeal carcinoma
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P698
P932